Biomea Fusion Inc.
Clinical trials sponsored by Biomea Fusion Inc., explained in plain language.
-
New diabetes pill shows promise in early trials
Disease control CompletedThis study tested a new daily pill, BMF-219, in healthy adults and people with type 2 diabetes. The goal was to check its safety and how well it controls blood sugar over 26 weeks. About 443 participants took either the drug or a placebo. The results will help decide if larger st…
Phase: PHASE1, PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Healthy volunteers test new drug capsule with and without food
Knowledge-focused CompletedThis phase 1 study looked at how the body absorbs icovamenib capsules when taken with or without food. Sixty healthy adults participated to help researchers understand the drug's behavior. The goal was to gather information, not to treat any disease.
Phase: PHASE1 • Sponsor: Biomea Fusion Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 05:51 UTC